■ 学術雑誌
|
原著
|
|
1.
|
松森 恵理, 中島 千寿, 大石 美栄, 大蔵 綾子, 朴 将源, 柴田 伸弘, 佐竹 悠良：
服薬支援アプリを用いた全人的患者支援の効果.
癌と化学療法
48
(12)
：1497
-1501
, 2021
|
|
2.
|
Ikoma T, Shimokawa M, Kotaka M, Matsumoto T, Nagai H, Boku S, Shibata N, Yasui H, Satake H.：
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan.
BMC cancer
21
(1)
：518
, 2021
|
|
3.
|
Kotaka M, Saito Y, Kato T, Satake H, Makiyama A, Tsuji Y, Shinozaki K, Fujiwara T, Mizushima T, Harihara Y, Nagata N, Kurihara N, Ando M, Kusakawa G, Sakai T, Uchida Y, Takamoto M, Kimoto S, Hyodo I：
Correction to: A placebo‑controlled, double‑blind, randomized study of recombinant thrombomodulin (ART‑123) to prevent oxaliplatin‑induced peripheral neuropathy.
Cancer chemotherapy and pharmacology
87
(4)
：585
-586
, 2021
|
|
4.
|
Ishibashi K, Aoyama T, Kotaka M, Satake H, Tsuji Y, Kataoka M, Nakamura M, Nagata N, Sakamoto J, Oba K, Mishima H.：
Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study).
Cancer chemotherapy and pharmacology
87
(5)
：665
-672
, 2021
|
|
5.
|
Yamamoto T, Satoi S, Yamaki S, Hashimoto D, Ishida M, Ikeura T, Hirooka S, Matsui Y, Boku S, Nakayama S, Nakamaru K, Shibata N, Katsushima U, Sekimoto M.：
Intraperitoneal Paclitaxel Treatment for Patients with Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination Provides a Survival Benefit.
Cancers
14
(5)
：1354
-1354
, 2022
|
|
6.
|
Yoshida T, Miki H, Satake H, Kobayashi T, Matsumi Y, Hamada M, Boku S, Shibata N, Ishida M, Sekimoto M.：
Pathological Complete Response of Clinical T4b Ascending Colon Cancer after Preoperative Chemotherapy Using Pembrolizumab.
Case reports in oncology
14
(3)
：1497
-1504
, 2021
|
|
7.
|
Ogata M, Ama Y, Ogata T, Hirabatake M, Yasui H, Satake H：
Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Patients With Active Cancer.
In vivo
35
(5)
：2747
-2753
, 2021
|
|
8.
|
Kato T, Kagawa Y, Kuboki Y, Gamoh M, Komatsu Y, Yasui H, Satake H, Oki E, Tanioka H, Kotaka M, Makiyama A, Denda T, Goto M, Yoshino T, Yamazaki K, Soeda J, Shibuya K, Iwata M, Oba K, Yamaguchi K.：
Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study.
International journal of clinical oncology
26
(7)
：1238
-1247
, 2021
|
|
9.
|
Nishimura M, Sakai H, Onoe T, Boku S, Yokoyama T, Kadokura G, Morita S, Katsumata N, Matsumoto K.：
4-step, 2-h carboplatin desensitization in Japanese patients with ovarian cancer: a prospective study.
International journal of clinical oncology
26
(8)
：1553
-1560
, 2021
|
|
10.
|
Kotani D, Yoshino T, Kotaka M, Kawazoe A, Masuishi T, Taniguchi H, Yamazaki K, Yamanaka T, Oki E, Muro K, Komatsu Y, Bando H, Satake H, Kato T, Tsuji A.：
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first-line treatment for metastatic colorectal cancer: Safety lead-in results from the QUATTRO-II study.
Investigational new drugs
39
(6)
：1649
-1655
, 2021
|
|
11.
|
Nakamura M, Satake H, Sagawa T, Takagane A, Sekikawa T, Oguchi K, Kaji T, Takeuchi M, Ichikawa W, Fujii M.：
18 F-FDG-PET/CT as an imaging biomarker for regorafenib efficacy in metastatic colorectal cancer (JACCRO CC-12).
Oncology & Chemotherapy
9
(2)
：635
-645
, 2021
|
|
12.
|
Satake H, Hashida H, Tanioka H, Miyake Y, Yoshioka S, Watanabe T, Matsuura M, Kyogoku T, Inukai M, Kotake T, Okita Y, Matsumoto T, Yasui H, Kotaka M, Kato T, Kaihara S, Tsuji A.：
Hepatectomy Followed by Adjuvant Chemotherapy with 3-Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases.
The oncologist
26
(7)
：e1125
-e1132
, 2021
|
|
症例報告
|
|
1.
|
Matsui Y, Hamada M, Matsumi Y, Sekimoto M, Ishida M, Satake H, Kurokawa H, Kinoshita H：
Curative resection of ureteral metastasis of rectal cancer: a case report and review of literature.
Clinical Journal of Gastroenterology
15
(1)
：151
-156
, 2022
|
|
■ 学会発表
|
全国規模の学会
|
|
1.
|
◎松本俊彦, 朴 将源, 堀 圭介, 堀 伸一郎, 松本祐介, 安井久晃, 牧山千夏, 井上健太郎, 佐竹悠良, 山﨑 誠：
化学療法＋Nivolumabを受けたHER2陰性胃がんに対するHER2発現と効果に関する検討.
第97回日本胃癌学会,
名古屋,
2022/03
|
|
その他
|
|
1.
|
生駒 龍興, 佐竹 悠良, 松本 俊彦, 朴 将源, 柴田 伸弘, 高谷 昌宏, 島田 貴信, 津村 剛彦, 永井 宏樹, 安井 久晃：
進行再発食道癌に対するニボルマブ単剤療法での予後予測因子に関する多施設共同研究.
第75回 日本食道学会学術集会,
Web,
2021/09
|
|
2.
|
朴 将源, 渡邉 元樹, 飯塚 まひろ, 曽和 義広, 増田 光治, 飯泉 陽介, 成田 匠, 佐竹 悠良, 酒井 敏行, 武藤 倫弘：
PIK3CA変異大腸癌細胞においてグルタミン代謝阻害がアスピリンに対する感受性を促進する.
日本癌学会総会記事 (0546-0476)80回,
Web,
2021/09
|
|
3.
|
木川 雄一郎, 吉田 奈央, 多田 真奈美, 朴 将源, 柴田 伸弘, 杉江 知治：
PROとClinRO PROを日常臨床にどう生かすか?.
日本乳癌学会総会プログラム抄録集 29回,
Web,
2021/07
|
|
4.
|
Shogen Boku, Hironaga Satake, Hiromi Mukaide, Makoto Yamazaki, Kentaro Inoue, Mitsugu Sekimoto：
Early response of Anamorelin in Gastric Cancer Patients.
第94回日本胃癌学会総会,
Web,
2022/03
|
|
5.
|
Shogen Boku, Hironaga Satake, Masataka Masuda, Takashi Ito, So Yamaki, Ko Nakamaru, Satoshi Hirooka, Daisuke Hashimoto, Tomohisa Yamamoto, Nobuhiro Shibata, Shinji Nakayama, Tsukasa Ikeura, Sohei Satoi, Mitsugu Sekimoto：
The analysis of forty-one unresectable or metastatic pancreatic cancer patients received with nanoliposomal irinotecan.
JSMO2022,
Web,
2022/02
|
|
